Suppr超能文献

结节病合并强直性脊柱炎:不断变化的治疗格局。

Sarcoidosis with ankylosing spondylitis: changing therapeutic landscape.

作者信息

Rahul Chinnabhathini Deva, Sharma Rahul Kumar, Talwar Deepak

机构信息

Metro Centre for Respiratory Diseases, Metro Multispecialty Hospital, Noida, UP, India.

出版信息

Sarcoidosis Vasc Diffuse Lung Dis. 2018;35(3):285-288. doi: 10.36141/svdld.v35i3.6679. Epub 2018 Apr 28.

Abstract

Sarcoidosis is an inflammatory multisystem disease which rarely may coexist in patients with other autoimmune disease like ankylosing spondylitis (AS). The presence of such as association causes diagnostic and management dilemmas as sarcoidosis has been reported to develop in patients of AS treated with tumour necrosis factor alpha (TNF-α) inhibitors. We describe a 49-year-old male with ankylosing spondylitis and histologically proven sarcoidosis who was treated with infliximab and improved. .

摘要

结节病是一种炎症性多系统疾病,极少情况下可能与强直性脊柱炎(AS)等其他自身免疫性疾病共存于患者体内。这种关联的存在会导致诊断和治疗困境,因为据报道,在接受肿瘤坏死因子α(TNF-α)抑制剂治疗的AS患者中会出现结节病。我们描述了一名49岁患有强直性脊柱炎且经组织学证实为结节病的男性患者,他接受了英夫利昔单抗治疗并病情好转。

相似文献

1
Sarcoidosis with ankylosing spondylitis: changing therapeutic landscape.
Sarcoidosis Vasc Diffuse Lung Dis. 2018;35(3):285-288. doi: 10.36141/svdld.v35i3.6679. Epub 2018 Apr 28.
4
Efficiency of adalimumab, etanercept and infliximab in ankylosing spondylitis in clinical practice.
Int J Clin Pharm. 2015 Oct;37(5):808-14. doi: 10.1007/s11096-015-0124-1. Epub 2015 Apr 25.
5
Composite Lymphoma after Treatment with Infliximab for Sarcoidosis and Ankylosing Spondylitis.
Intern Med. 2025 Jan 1;64(1):129-132. doi: 10.2169/internalmedicine.3274-23. Epub 2024 Jun 6.
6
Refractory vertebral sarcoidosis responding to infliximab.
J Clin Rheumatol. 2008 Aug;14(4):238-40. doi: 10.1097/RHU.0b013e318181b45a.
7
The Safety Profile of Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis: Are TNF Inhibitors Safer Than We Thought?
J Clin Pharmacol. 2019 Apr;59(4):445-462. doi: 10.1002/jcph.1348. Epub 2018 Nov 26.
9
Infliximab: in ankylosing spondylitis.
Drugs. 2005;65(9):1283-91; discussion 1292-4. doi: 10.2165/00003495-200565090-00006.

本文引用的文献

1
Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis.
Eur Respir J. 2015 Jul;46(1):175-85. doi: 10.1183/09031936.00227014. Epub 2015 Apr 30.
2
New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication.
Intern Med J. 2012 Jan;42(1):89-94. doi: 10.1111/j.1445-5994.2011.02612.x.
3
Advances in the genetics of sarcoidosis.
Clin Genet. 2008 May;73(5):401-12. doi: 10.1111/j.1399-0004.2008.00970.x. Epub 2008 Feb 26.
4
Pulmonary sarcoidosis associated with etanercept therapy.
Pharmacotherapy. 2007 Oct;27(10):1446-8. doi: 10.1592/phco.27.10.1446.
6
Effectiveness of infliximab in treating selected patients with sarcoidosis.
Respir Med. 2006 Nov;100(11):2053-9. doi: 10.1016/j.rmed.2006.02.017. Epub 2006 Aug 28.
7
Recent advances in the treatment of the spondyloarthropathies.
Curr Opin Rheumatol. 2004 Jul;16(4):357-65. doi: 10.1097/01.bor.0000129719.21563.35.
9
Sarcoidosis and spondylarthropathy. Three case-reports.
Rev Rhum Engl Ed. 1996 Jun;63(6):405-11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验